(Q36487892)

14 August 2017

1 reference

title

Hepatitis C virus infection in Scotland: epidemiological review and public health challenges (English)

1 reference

14 August 2017

0 references

1 reference

1 reference

1

S J Hutchinson

1 reference

14 August 2017

K M Roy

2

1 reference

14 August 2017

S Wadd

3

1 reference

14 August 2017

S M Bird

4

1 reference

14 August 2017

A Taylor

5

1 reference

14 August 2017

E Anderson

6

1 reference

14 August 2017

L Shaw

7

1 reference

14 August 2017

G Codere

8

1 reference

14 August 2017

D J Goldberg

9

1 reference

14 August 2017

publication date

1 May 2006

1 reference

14 August 2017

published in

Scottish Medical Journal

1 reference

14 August 2017

volume

51

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

8-15

1 reference

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Methods of transmission of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Conservation of the cag pathogenicity island is associated with vacA alleles and gastroduodenal disease in South African Helicobacter pylori isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Hepatitis C virus among childbearing women in Scotland: prevalence, deprivation, and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

HCV prevalence in pregnant women in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

European paediatric hepatitis C virus network. Antenatal hepatitis C virus screening and management of infected women and their children: policies in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Detection of hepatitis C virus antibodies and specific hepatitis C virus ribonucleic acid sequences in cord bloods from a heterogeneous prenatal population

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

The feasibility and acceptability of collecting oral fluid from healthy children for anti-HCV testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Patterns of age- and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Use of several second generation serological assays to determine the true prevalence of hepatitis C virus infection in haemophiliacs treated with non-virus inactivated factor VIII and IX concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Haemophilia, blood products and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Risk of hepatitis C virus transmission from patients to surgeons: model based on an unlinked anonymous study of hepatitis C virus prevalence in hospital patients in Glasgow

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

A study of hepatitis C prevalence in healthcare workers in the West of Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Prevalence of hepatitis C antibodies in clinical health-care workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Hepatitis C infection among dental personnel in the West of Scotland, UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Hepatitis C virus among genitourinary clinic attenders in Scotland: unlinked anonymous testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Prevalence of hepatitis C among injectors in Scotland 1989-2000: declining trends among young injectors halt in the late 1990s.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

High risk injecting behaviour among injectors from Glasgow: cross sectional community wide surveys 1990-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Projecting future complications of chronic hepatitis C in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Comparing the public health burden of chronic hepatitis C and HIV infection in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Simulation of hepatitis C based on a mandatory reporting system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

Hepatitis virus infection and liver disease in injecting drug users who died suddenly

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FRSMSMJ.51.2.8

21 January 2018

Identifiers

DOI

10.1258/RSMSMJ.51.2.8

1 reference

14 August 2017

1 reference